Michael E. Lidsky

3.1k total citations · 1 hit paper
71 papers, 1.6k citations indexed

About

Michael E. Lidsky is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael E. Lidsky has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 40 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael E. Lidsky's work include Pancreatic and Hepatic Oncology Research (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). Michael E. Lidsky is often cited by papers focused on Pancreatic and Hepatic Oncology Research (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). Michael E. Lidsky collaborates with scholars based in United States, China and Netherlands. Michael E. Lidsky's co-authors include Peter J. Allen, Charles Kim, Dimitrios Moris, James D. Sidman, Timothy A. Lander, Michael A. Morse, Manisha Palta, Ryan S. Turley, Paul J. Speicher and Dan G. Blazer and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Annals of Surgery.

In The Last Decade

Michael E. Lidsky

59 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

2022 261 citations Dimitrios Moris, Manisha Palta et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Lidsky United States	21	883	600	533	200	185	71	1.6k
P. Kienle Germany	21	845 1.0×	359 0.6×	1.0k 1.9×	205 1.0×	49 0.3×	73	1.7k
Giuseppe Nigri Italy	32	2.0k 2.2×	1.0k 1.7×	1.7k 3.2×	78 0.4×	163 0.9×	147	3.2k
Eduardo Fernandes United States	22	767 0.9×	538 0.9×	456 0.9×	50 0.3×	81 0.4×	71	1.5k
Masayuki Chida Japan	23	516 0.6×	1.0k 1.7×	409 0.8×	56 0.3×	66 0.4×	150	1.7k
S. Rohr France	19	790 0.9×	253 0.4×	317 0.6×	75 0.4×	58 0.3×	114	1.2k
Ahmet Ayav France	28	1.8k 2.0×	546 0.9×	843 1.6×	55 0.3×	659 3.6×	107	2.7k
Steinar Solberg Norway	22	703 0.8×	1.0k 1.7×	460 0.9×	46 0.2×	416 2.2×	63	2.0k
Seung Eun Lee South Korea	28	1.9k 2.1×	1.1k 1.8×	1.3k 2.4×	59 0.3×	122 0.7×	114	2.4k
Abdurrahman Işıkdoğan Türkiye	19	204 0.2×	424 0.7×	537 1.0×	79 0.4×	69 0.4×	146	1.2k
C Garrone Italy	23	1.6k 1.8×	310 0.5×	733 1.4×	130 0.7×	230 1.2×	38	1.9k

Countries citing papers authored by Michael E. Lidsky

Since Specialization

Citations

This map shows the geographic impact of Michael E. Lidsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Lidsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Lidsky more than expected).

Fields of papers citing papers by Michael E. Lidsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Lidsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Lidsky. The network helps show where Michael E. Lidsky may publish in the future.

Co-authorship network of co-authors of Michael E. Lidsky

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Lidsky. A scholar is included among the top collaborators of Michael E. Lidsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Lidsky. Michael E. Lidsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Annie, Jaehun Jung, William R. Jarnagin, et al.. (2025). Robotic Versus Open Placement of Hepatic Artery Infusion Pumps. Annals of Surgical Oncology. 32(5). 3488–3498.

Merkow, Ryan P., Michael J. Cavnar, Ana Gleisner, et al.. (2025). Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Annals of Surgical Oncology. 32(6). 4408–4416.

Moris, Dimitrios, Alessandro Martinino, Peter J. Allen, et al.. (2025). Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. CA A Cancer Journal for Clinicians. 75(6). 498–527. 9 indexed citations

Tuttle, Brandi, et al.. (2025). Use of Virtual Oncology in Hepatopancreatobiliary Cancers: A Scoping Review. Annals of Surgical Oncology. 33(1). 624–637.

Blair, Alex B., Joanne F. Chou, Mei Liu, et al.. (2024). Survival outcomes and genetic characteristics of resected pancreatic acinar cell carcinoma. HPB. 26. S625–S625.

Masoud, Sabran, Michael E. Lidsky, Garth S. Herbert, et al.. (2024). Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency. Annals of Surgical Oncology. 31(12). 8287–8297.

Chen, Qichen, Kan Li, Kristen E. Rhodin, et al.. (2023). Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases. Journal of Surgical Oncology. 127(6). 945–955. 1 indexed citations

Chen, Qichen, Kan Li, Kristen E. Rhodin, et al.. (2023). Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival. HPB. 26(1). 125–136. 1 indexed citations

Rhodin, Kristen E., Sabran Masoud, Alex J. Bartholomew, et al.. (2023). Tumor size and survival in intrahepatic cholangiocarcinoma treated with surgical resection or ablation. Journal of Surgical Oncology. 128(8). 1329–1339. 4 indexed citations

10.

Masoud, Sabran, Kristen E. Rhodin, Alex J. Bartholomew, et al.. (2023). Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 30(11). 6639–6646. 4 indexed citations

11.

Cavnar, Michael J., Michael E. Lidsky, Ismael Domínguez-Rosado, et al.. (2022). Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. HPB. 24(12). 2104–2111. 14 indexed citations

12.

Landa, Karenia, Robin Schmitz, Norma E. Farrow, et al.. (2021). Surgical resection is associated with improved long-term survival of patients with resectable pancreatic head cancer compared to multiagent chemotherapy. HPB. 24(7). 1153–1161. 5 indexed citations

13.

Turner, Megan C., Carrie Moore, John M. Creasy, et al.. (2021). Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases. Journal of Gastrointestinal Surgery. 26(4). 764–771. 7 indexed citations

14.

Moris, Dimitrios, Marcelo Cerullo, Robin Schmitz, et al.. (2021). Empiric nasogastric decompression after pancreaticoduodenectomy is not necessary. HPB. 23(12). 1906–1913. 3 indexed citations

15.

Lidsky, Michael E., Paul J. Speicher, Brian Ezekian, et al.. (2017). Subtotal cholecystectomy for the hostile gallbladder: failure to control the cystic duct results in significant morbidity. HPB. 19(6). 547–556. 46 indexed citations

16.

Li, George Z., Paul J. Speicher, Michael E. Lidsky, et al.. (2014). Hepatic Resection for Hepatocellular Carcinoma: Do Contemporary Morbidity and Mortality Rates Demand a Transition to Ablation as First-Line Treatment?. Journal of the American College of Surgeons. 218(4). 827–834. 21 indexed citations

17.

Lidsky, Michael E., Julie K. Thacker, Sandhya Lagoo‐Deenadayalan, & John Scarborough. (2012). Advanced age is an independent predictor for increased morbidity and mortality after emergent surgery for diverticulitis. Surgery. 152(3). 465–472. 55 indexed citations

18.

Peng, Peter D., Omar Hyder, Michael N. Mavros, et al.. (2012). Management and Recurrence Patterns of Desmoids Tumors: A Multi-institutional Analysis of 211 Patients. Annals of Surgical Oncology. 19(13). 4036–4042. 99 indexed citations

19.

Lidsky, Michael E., Charles E. Spritzer, & Cynthia K. Shortell. (2012). The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations. Journal of Vascular Surgery. 56(3). 757–764.e1. 23 indexed citations

20.

Turley, Ryan S., Andrew S. Barbas, Michael E. Lidsky, et al.. (2012). Laparoscopic Versus Open Hartmann Procedure for the Emergency Treatment of Diverticulitis. Diseases of the Colon & Rectum. 56(1). 72–82. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact